| Literature DB >> 27736918 |
Sayaka Myojin1, Takeru Yoshimura1, Shigeo Yoshida1, Atsunobu Takeda1, Yusuke Murakami1, Yoichi Kawano2, Yuji Oshima1, Tatsuro Ishibashi1, Koh-Hei Sonoda1.
Abstract
PURPOSE: The analysis of gene expression in idiopathic epiretinal membranes (iERMs) may help elucidate ERM formation and its pathology. Here, we conducted a case-control study, in order to determine the expression levels of cytokines and other genes in eyes with macular hole (MH) or iERM.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27736918 PMCID: PMC5063277 DOI: 10.1371/journal.pone.0164355
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographics of Patients Included in Macular Hole and Idiopathic Epiretinal Membrane Groups.
| Macular hole eyes | Epiretinal membrane eyes | ||
|---|---|---|---|
| Study population, number (%) | 5 (25) | 15 (75) | |
| Age, mean (SD), years | 61.8 (5.84) | 71.5 (6.59) | < 0.05 |
| Gender, number | 0.61 | ||
| Male, 7 | 1 | 6 | |
| Female, 13 | 4 | 9 | |
| Operation time, mean (SD), min | 61 (14) | 61 (12) | 0.98 |
SD, standard deviation.
†t-test or,
‡Fisher’s exact test were used for the comparisons between the two groups.
Expression Levels of Cytokines and Other Investigated Genes in the Solid Component of the Irrigation Solution.
| Gene | Comparative Ct method | ||||
|---|---|---|---|---|---|
| ΔCt (SD) | ΔΔCt (SD) | Fold-change value; 2-ΔΔCt | |||
| Epiretinal membrane | Macular hole | ||||
| 8.63 (1.62) | 10.8 (1.48) | -1.96 (0.136) | 4.4 | < 0.05 | |
| N.D. | N.D. | N/A | N/A | N/A | |
| 3.66 (1.10) | 3.57 (0.927) | -0.0112 (0.254) | 0.94 | 0.83 | |
| 4.65 (0.961) | 7.63 (2.19) | -3.26 (1.48) | 7.9 | < 0.001 | |
| 8.81 (1.46) | 8.75 (1.11) | 0.330(0.662) | 0.96 | 0.90 | |
| 16.5 (1.48) | 15.3 (3.12) | 0.616 (1.99) | 0.43 | 0.49 | |
| 3.45 (1.03) | 6.58 (1.20) | -3.27 (0.317) | 8.7 | < 0.001 | |
| 4.82 (1.45) | 4.02 (1.75) | 0.919 (0.302) | 0.57 | 0.42 | |
| 9.88 (1.36) | 8.90 (3.00) | 0.658 (1.53) | 0.51 | 0.20 | |
| 6.87 (1.71) | 8.80 (1.14) | -2.26 (0.0509) | 3.8 | < 0.01 | |
| 12.0 (1.86) | 9.32 (1.26) | 2.88 (0.766) | 0.16 | 0.29 | |
| 7.83 (0.783) | 8.47 (0.321) | -0.980 (0.449) | 1.6 | < 0.05 | |
| 6.82 (0.585) | 7.31 (0.805) | -0.393 (0.104) | 1.4 | 0.25 | |
| 13.0 (1.33) | 12.7 (1.25) | -0.0011 (0.339) | 0.83 | 0.99 | |
| 12.1 (1.67) | 11.4 (2.63) | 0.235 (1.02) | 0.61 | 0.41 | |
| N.D. | N.D. | N/A | N/A | N/A | |
| 0.658 (1.24) | 2.14 (1.04) | -1.46 (0.0919) | 2.8 | < 0.05 | |
| 2.91 (2.10) | 5.45 (0.959) | -2.96 (0.308) | 5.8 | < 0.005 | |
| 14.8 (2.29) | 8.47 (0.740) | 5.23 (1.15) | 0.013 | 0.26 | |
N.D., not detected; N/A, not applicable; IL, interleukin; TGF, tumor growth factor; TNF, tumor necrosis factor; IFNG, interferon-γ; VEGF, vascular endothelial growth factor; CCL, chemokine C-C motif ligand; CXCL, chemokine C-X-C motif ligand; RELA, v-rel avian reticuloendotheliosis viral oncogene homolog A; STAT, signal transducer and activator of transcription; RORC, retinoic acid receptor-related orphan receptor gamma; TBX, T-box protein; ACTA1, actin, alpha 1, skeletal muscle; GFAP, glial fibrillary acidic protein; TNC, tenascin C; POSTN, periostin.
† t-test or,
‡ Welch’s t-test were used for the comparisons between the two groups.
# Undetectable in three out of five eyes with macular hole.
Spearman’s Correlation Coefficients between the Seven Upregulated Genes and Preoperative Visual Acuity of Eyes with Idiopathic Epiretinal Membrane.
| Spearman correlation coefficients, ρ ( | |||||||
|---|---|---|---|---|---|---|---|
| Preoperative visual acuity | -0.153 (0.62) | 0.178 (0.53) | -0.166 (0.55) | 0.195 (0.49) | 0.0911 (0.75) | 0.102 (0.73) | -0.186 (0.51) |
IL, interleukin; TGF, tumor growth factor; VEGF, vascular endothelial growth factor; CXCL, chemokine C-X-C motif ligand; RELA, v-rel avian reticuloendotheliosis viral oncogene homolog A; GFAP, glial fibrillary acidic protein; TNC, tenascin C.
Spearman’s Correlation Coefficient Analysis of the Expression Levels of Seven Genes in Eyes with Idiopathic Epiretinal Membrane.
| Spearman’s correlation coefficients | ||
|---|---|---|
| ρ | ||
| 0.762 | < 0.005 | |
| 0.110 | 0.72 | |
| 0.423 | 0.15 | |
| 0.300 | 0.31 | |
| 0.189 | 0.56 | |
| 0.209 | 0.49 | |
| 0.0519 | 0.85 | |
| 0.648 | < 0.01 | |
| 0.597 | < 0.05 | |
| 0.260 | 0.37 | |
| 0.385 | 0.16 | |
| -0.281 | 0.31 | |
| -0.0680 | 0.81 | |
| 0.624 | < 0.05 | |
| 0.686 | < 0.005 | |
| 0.476 | 0.073 | |
| -0.0882 | 0.76 | |
| 0.129 | 0.65 | |
| 0.199 | 0.50 | |
| 0.335 | 0.22 | |
| 0.705 | < 0.005 | |
IL, interleukin; TGF, tumor growth factor; VEGF, vascular endothelial growth factor; CXCL, chemokine C-X-C motif ligand; RELA, v-rel avian reticuloendotheliosis viral oncogene homolog A; GFAP, glial fibrillary acidic protein; TNC, tenascin C.
Fig 1A model illustrating the putative relationship between the seven genes shown to be upregulated in iERM eyes.